Standout Papers

Management of toxicities of immune checkpoint inhibitors 2016 2026 2019 2022 660
  1. Management of toxicities of immune checkpoint inhibitors (2016)
    Lavinia Spain, Stefan Diem et al. Cancer Treatment Reviews
  2. Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab (2017)
    Stefan Diem, Sabine Schmid et al. Lung Cancer

Immediate Impact

1 by Nobel laureates 7 from Science/Nature 70 standout
Sub-graph 1 of 21

Citing Papers

Ultrasound-Based Micro-/Nanosystems for Biomedical Applications
2024 Standout
Polymeric Nanoparticles for Drug Delivery
2024 Standout
4 intermediate papers

Works of Stefan Diem being referenced

Tumor infiltrating lymphocytes in lymph node metastases of stage III melanoma correspond to response and survival in nine patients treated with ipilimumab at the time of stage IV disease
2017
Management of toxicities of immune checkpoint inhibitors
2016 Standout

Author Peers

Author Last Decade Papers Cites
Stefan Diem 2139 609 286 603 31 2.5k
Lavinia Spain 1778 447 284 613 54 2.2k
Ian M. Waxman 2220 704 429 970 35 2.7k
Leila Khoja 1633 389 408 596 50 2.1k
Claire F. Friedman 1511 526 273 435 74 2.0k
Niamh M. Long 1421 279 414 668 22 1.9k
David B. Page 2306 1227 588 609 60 3.2k
Ira Wollner 2580 1341 481 727 31 3.3k
Sofiya Latifyan 1377 524 275 377 24 1.8k
William J. Geese 2415 608 472 1375 42 2.9k
Kristen A. Marrone 1395 403 439 719 71 1.9k

All Works

Loading papers...

Rankless by CCL
2026